Australia markets closed

Qualis Innovations, Inc. (QLIS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.2601-0.0029 (-1.10%)
At close: 09:30AM EDT

Qualis Innovations, Inc.

225 Wilmington West Chester Pike
Suite 200 #145
Chadds Ford, PA 19317
United States
484 483 2134
https://www.qualisinnovations.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Patrick S. Adams C.F.A., CFAActing CEO & Chairman of the BoardN/AN/A1961
Mr. James ThurmanSenior Vice President of Corporate & IR CommunicationsN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Qualis Innovations, Inc., a clinical stage company, focuses on the development, production, and distribution of pain management and other central nervous system (CNS) based solutions in the United States. Its lead product is SOLACE, a non-invasive medical device to use electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. Qualis Innovations, Inc. is headquartered in Chadds Ford, Pennsylvania.

Corporate governance

Qualis Innovations, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.